Lyra Morina
@lmorina.bsky.social
MD-PhD student, GR2 | Washington University in St. Louis | Fehniger Lab
#NKcells #CARNKcells #celltherapy #immunotherapy #follicularlymphoma | opinions my own
#NKcells #CARNKcells #celltherapy #immunotherapy #follicularlymphoma | opinions my own
Reposted by Lyra Morina
As more people migrate over to @bsky.app sharing this updated #starterpack for transplant, cell and Gene therapy #bmtsm #geneRx #cartcells go.bsky.app/7xxh8WW
January 27, 2025 at 6:25 PM
As more people migrate over to @bsky.app sharing this updated #starterpack for transplant, cell and Gene therapy #bmtsm #geneRx #cartcells go.bsky.app/7xxh8WW
Reposted by Lyra Morina
Good morning, Bluesky. Today’s #GoodMorningNews: a trial at Washington University’s school of medicine has shown great results for a vaccine that would prevent recurrence for a particularly aggressive form of breast cancer. It’s a small trial, but 3 years later 16/18 participants remain cancer free
Vaccine shows promise against aggressive breast cancer | WashU Medicine
Clinical trial targeted recurrence of hard-to-treat triple-negative breast cancer
medicine.washu.edu
November 16, 2024 at 3:09 PM
Good morning, Bluesky. Today’s #GoodMorningNews: a trial at Washington University’s school of medicine has shown great results for a vaccine that would prevent recurrence for a particularly aggressive form of breast cancer. It’s a small trial, but 3 years later 16/18 participants remain cancer free